Clinical landscape of LAG-3-targeted therapy by Chocarro, L., Blanco, E., Arasanz, H., Fernández-Rubio, L., Bocanegra, A., Echaide, M., Garnica, M., Ramos, P., Fernández-Hinojal, G., Vera, R., Kochan, G., Escors, D.

Get full text

110MO CD8 T cells are responsible for the PD-1, LAG-3 and CBL-B triple blockade therapeutic antitumor effect by Chocarro, L., Blanco, E., Fenández-Rubio, L., Garnica, M., Zuazo, M., Granda, M.J. Garcia, Bocanegra, A., Echaide, M., Johnston, C., Edwards, C.J., Legg, J., Pierce, A., Arasanz, H., Fernandez-Hinojal, G., Vera, R., Ausin, K., Santamaría, E., Fernández-Irigoyen, J., Kochan, G., Escors, D.

Get full text

87P Clinical features and genetic profile of MDM2-altered solid tumors by Tejerina-Peces, J., Bartolomé Arcilla, J., De La Hoya, M., Garre, P., Paz Cabezas, M., López de Sá, A., Cabezas-Camarero, S., García Paredes, B., Vidal Cassinello, N., Aguado, C., Marquina Ospina, G., Fernandez-Hinojal, G., Orta, A., Ortega, L., Ocana Fernandez, A., Pérez Segura, P., Manzano Fernández, A.

Get full text

Plasma fractalkine contributes to systemic myeloid diversity and PD‐L1/PD‐1 blockade in lung cancer by Bocanegra, Ana, Fernández‐Hinojal, Gonzalo, Ajona, Daniel, Blanco, Ester, Zuazo, Miren, Garnica, Maider, Chocarro, Luisa, Alfaro‐Arnedo, Elvira, Piñeiro‐Hermida, Sergio, Morente, Pilar, Fernández, Leticia, Remirez, Ana, Echaide, Miriam, Martinez‐Aguillo, Maite, Morilla, Idoia, Tavira, Beatriz, Roncero, Alejandra, Gotera, Carolina, Ventura, Alfonso, Recalde, Nerea, Pichel, José G, Lasarte, Juan José, Montuenga, Luis, Vera, Ruth, Pio, Ruben, Escors, David, Kochan, Grazyna

Get full text